Ohio Public Employees Retirement System (OPERS)
RNAC icon

Ohio Public Employees Retirement System (OPERS)’s Cartesian Therapeutics RNAC Stock Holding History

Ohio Public Employees Retirement System (OPERS)’s Portfolio RNAC Stock Details RNAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$80K Sell
13,000
-2,500
-16% -$17.8K ﹤0.01% 1828
2025
Q4 		$112K Buy
+15,500
New +$125K ﹤0.01% 1777
2022
Q1 		– Sell
-2,809
Closed -$275K – 2048
2021
Q4 		$275K Sell
2,809
-50
-2% -$5.38K ﹤0.01% 1433
2021
Q3 		$357K Sell
2,859
-200
-7% -$24.2K ﹤0.01% 1389
2021
Q2 		$384K Hold
3,059
– – ﹤0.01% 1384
2021
Q1 		$415K Buy
3,059
+838
+38% +$104K ﹤0.01% 1357
2020
Q4 		$202K Buy
+2,221
New +$193K ﹤0.01% 1415

Other funds holding RNAC

Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ohio Public Employees Retirement System (OPERS)'s RNAC Position: Q1 2026 in Review

Ohio Public Employees Retirement System (OPERS) reduced its Cartesian Therapeutics (RNAC) stake by 16% in Q1 2026, selling an estimated $17.8K and leaving 13,000 shares worth $80K. The position accounts for ﹤0.01% of the portfolio, ranked #1828.

Ohio Public Employees Retirement System (OPERS) first reported a position in RNAC in Q4 2020 and has held it in 7 quarters since. The position peaked at $415K in Q1 2021. 83 funds tracked by Wall St. Rank hold RNAC as of Q1 2026.

  • Ohio Public Employees Retirement System (OPERS) held 13,000 shares of Cartesian Therapeutics worth $80K as of Q1 2026.
  • Ohio Public Employees Retirement System (OPERS) sold 2,500 Cartesian Therapeutics shares in Q1 2026, an estimated $17.8K.
  • Cartesian Therapeutics made up ﹤0.01% of Ohio Public Employees Retirement System (OPERS)'s portfolio in Q1 2026, its #1828 holding.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Cartesian Therapeutics in Q4 2020 and has held it in 7 quarters since.
  • Ohio Public Employees Retirement System (OPERS)'s Cartesian Therapeutics position peaked at $415K in Q1 2021.
  • 83 funds tracked by Wall St. Rank held Cartesian Therapeutics as of Q1 2026.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q1 2026, filed 14 May 2026.